`
`Lupin
`
`≡ MENU
`
`
`
`
`
`The Lupin Story (the-lupin-story.php)
`
`Corporate Overview
`
`Vision & Values (about-vision-values.php)
`
`Management (management.php)
`
`History & Milestones (history-milestone.php)
`
`Awards & Accolades (awards-accolades.php)
`
`CORPORATE OVERVIEW
`AN INNOVATION LED TRANSNATIONAL
`PHARMACEUTICAL COMPANY
`
`HOME (index.php) > OUR WORLD > ABOUT US > CORPORATE OVERVIEW (corporateoverview.php)
`
`HEADQUARTERED IN MUMBAI, INDIA, LUPIN LIMITED TODAY IS AN INNOVATION LED TRANSNATIONAL PHARMACEUTICAL COMPANY PRODUCING A WIDE RANGE OF QUALITY, AFFORDABLE GENERIC AND
`BRANDED FORMULATIONS AND APIs FOR THE DEVELOPED AND DEVELOPING MARKETS OF THE WORLD.
`
`Dr. Desh Bandhu Gupta's vision and dream to fight life threatening infectious diseases and to manufacture drugs of the highest social priority led to the formation of Lupin in the
`year 1968. His Vision, his inimitable commitment and verve have steered Lupin to achieving the distinction of becoming one of the fastest growing Generic pharmaceutical
`companies globally. Lupin first gained recognition when it became one of the world's largest manufacturers of Tuberculosis drugs. The Company today has significant market share
`in key markets in the Cardiovascular (prils and statins), Diabetology, Asthma, Pediatrics, CNS, GI, AntiInfectives and NSAIDs therapy segments, not to mention global leadership
`positions in the AntiTB and Cephalosporins segments.
`
`The Company's R&D endeavours have resulted in significant progress in its NCE program. The Company's foray into Advanced Drug Delivery Systems has resulted in the
`development of platform technologies that are being used to develop valueadded generic pharmaceuticals. Lupin's world class manufacturing facilities, spread across India and
`Japan, have played a critical role in enabling the companies realize its global aspirations. Benchmarked to International standards, these facilities are approved by international
`regulatory agencies like US FDA, UK MHRA, Japan's MHLW, TGA Australia, WHO, and the MCC South Africa. Our Drugs and products reach over 100 countries in the world.
`
`Today, Lupin has emerged as the 6th largest and the fastest growing Top 10 company in the US (by prescriptions), the only Asian company to achieve that distinction. The company
`is the 3rd largest Indian pharmaceutical company by sales. The Company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS). Lupin's
`Consolidated turnover and Profit after Tax were 125,997 million (USD 2.06 billion) and 24,032 million (USD 393 million) respectively for the FY 201415.
`
`"Embedded in Lupin is a formula for growth which fuels creativity, performance and innovation"
`
`Dr. Desh Bandhu Gupta
`Founder and Chairman
`
`http://www.lupin.com/corporateoverview.php
`
`1/2
`
`Page 1 of 2
`
`SENJU EXHIBIT 2261
`LUPIN v. SENJU
`IPR2015-01097
`
`
`
`12/28/2015
`
`Lupin
`
`DOWNLOAD FINANCIAL HIGHLIGHTS (HTTP://WWW.LUPIN.COM/FINANCIALS.PHP)
`
`Privacy (privacy.php) | Disclaimer (disclaimer.php) | Sitemap (sitemap.php)
`
`© LUPIN. ALL RIGHTS RESERVED
`
`http://www.lupin.com/corporateoverview.php
`
`2/2
`
`Page 2 of 2